Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-08-20

FDA Approved: PROCTOZONE-HC — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved Rising Pharma's PROCTOZONE-HC (hydrocortisone 2.5%), an original ANDA for a generic topical corticosteroid product. The approval provides a generic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROCTOZONE-HC (HYDROCORTISONE 2.5%)

Snippet

ORIG AP for PROCTOZONE-HC (HYDROCORTISONE 2.5%)